Equillium (EQ) Research & Development (2018 - 2026)

Equillium (EQ) has 9 years of Research & Development data on file, last reported at $3.0 million in Q1 2026.

• On a quarterly basis, Research & Development fell 49.51% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $14.5 million, a 56.76% decrease from a year earlier, with the FY2025 full-year figure at $12.8 million, down 65.69% from the prior year.
• Research & Development for Q1 2026 stood at $3.0 million, up from $1.5 million in the prior quarter.
• Over the last five years, Research & Development for EQ reached as high as $10.8 million in Q2 2024 and fell as low as $400000.0 in Q3 2025.
• Historically, Research & Development has averaged $7.5 million across 5 years, with a median of $9.0 million in 2023.
• Across the five-year window, Research & Development jumped 83.04% in 2022 and slumped 95.82% in 2025, its largest moves.
• Year by year, Research & Development stood at $8.5 million in 2022, then rose by 7.73% to $9.2 million in 2023, then dropped by 20.35% to $7.3 million in 2024, then tumbled by 79.0% to $1.5 million in 2025, then jumped by 94.73% to $3.0 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $3.0 million in Q1 2026, $1.5 million in Q4 2025, and $400000.0 in Q3 2025.